Log in using OpenID

Cell Therapy Manufacturing Market Analysis and Development Trends 2018-2026

Increasing number of surgical procedures performed across the world coupled with increasing number of trauma and accidents is propelling demand for new medical therapy.
Cell Therapy Manufacturing Market Size,
Share, Trend, Outlook, Future Analysis And
Synthesis By 2026
Cell therapy is one of the most promising healthcare procedure for restoration of damaged tissue. Cell
therapies have huge potential for the wide range of disease treatment including tissue degradation,
immune deficiency, metabolic disorders, and cancer. Cell therapy are categorized into two type’s
allogeneic (cells from third party donor) and autologous (cells from one’s own body). Cell therapy has
gained significant traction in recent past and currently it under commercial development. Main objective
of cell therapy is to re-establish the lost function of tissues and cells rather than to produce a new
organ. Some cell therapies have been established and permitted for clinical trial. For instance, in 2013 a
stage 2 clinical trial was completed for transplantation of bone marrow derived stem cells in affected
knee by rheumatoid arthritis. The growth of this technique is also increased due to involvement of the
government agencies. For instance, innovate U.K. 2014 report showed that government agreed to fund
US$15.3 million in cell therapy manufacturing market.
Get In-Depth Sample Copy of Research @
Cell Therapy Manufacturing Market Dynamics
Increasing number of surgical procedures performed across the world coupled with increasing number of
trauma and accidents is propelling demand for new medical therapy. For instance, according to a 2015,
World Health Organization (WHO) report, more than 50,000 stem cell transplants are carried out
annually worldwide for various surgeries. Stem cells transplantation is promising medical therapy for
patients with advance stage diseases like Alzheimer’s, arthritis, autism, blindness, cancer, cerebral palsy,
diabetes etc. Key biopharmaceutical companies are majorly investing in research for cell therapy. For
instance, Longeveron LL, a biopharmaceutical company received a US$ 750,000 grant from the Maryland
Technology Development Corporation (TEDCO) in 2018 for stem cell therapy research. These
collaborations and government funding are boosting growth of the cell therapy manufacturing market.
However, the strict regulations, guidelines, and various health safety concerns over cell therapy
treatment are restraining growth of the cell therapy market.
Cell Therapy Manufacturing Market - Regional Insights
On the basis of the region, the global cell therapy market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant
position in the global cell therapy manufacturing market, owing to large number of surgeries
performed in the region as well as development of technologically advanced products for
therapy. According to the National Health Statistics Report by the Centers for Disease Control &
Prevention (CDC), around 201,748.3 million surgical and non-surgical procedures were
performed in the U.S. in 2011.
Report includes chapters which deeply display the following deliverable about industry :
• Cell Therapy Manufacturing Market Research Objective and Assumption
• Cell Therapy Manufacturing Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Cell Therapy Manufacturing Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cell Therapy Manufacturing Market, By Regions
• Cell Therapy Manufacturing Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cell Therapy Manufacturing Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Cell Therapy Manufacturing Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cell Therapy Manufacturing Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Cell Therapy Manufacturing Market - Competitive Insights
The key player operating in the global cell therapy manufacturing market include,
Pharmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH,
Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics,
Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics,
Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS, MaSTherCell, PharmaCell, Cognate
BioServices and WuXi AppTec. Key players are adoption growth strategies such as collaborations,
introduction of new technologies and devices to maintain dominant position in the market. For instance,
in 2014, ViaCyte, Inc. successfully implanted VC-01 an embryonic stem cell derived islet for the
treatment of type 1 diabetes.
Cell Therapy Manufacturing Market Taxonomy:
On the basis of therapy type, the global cell therapy manufacturing market is segmented into:
Allogeneic Cell Therapy
Autologous Cell Therapy
On the basis of Technology:
Somatic Cell Technology
Cell Immortalization Technology
Viral Vector Technology
Genome Editing Technology
Cell Plasticity Technology
3D Technology
For More Details About This Exclusive Research, Talk to Our Analyst @
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Poul Master
Poul Master247   documents Email
Health and Medicine
File Size
121 KB
Cell Therapy Manufacturing Market, manufacturing
Report inappropriate content